Product Information
OXYBUTYNIN 5 MG TABLET is a generic product labeled by Strides Pharma Inc., priced at $0.0473 per EA under NDC 64380016203. Its NADAC has been published 204 times since Aug 3, 2022.
Strength
5 mg/1
Manufacturer
Strides Pharma Inc.NDC
64380016203
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
OXYBUTYNIN CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075079On Market Since
4/4/2022
Pharmacological Classes
Price Statistics
The NADAC for OXYBUTYNIN 5 MG TABLET has been published 204 times since Aug 3, 2022, and over the history we have for it it has declined 31.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0473 per EA |
|---|---|
| All-time high | $0.0765 (Nov 16, 2022) |
| All-time low | $0.0448 (Nov 20, 2024) |
| 52-week high | $0.0505 |
| 52-week low | $0.0455 |
| Median price | $0.0522 |
| Average price | $0.0560 |
| Largest weekly change | -28.1% (Apr 17, 2024) |
| Weeks tracked | 204 |
| Tracking since | Aug 3, 2022 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of OXYBUTYNIN 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXYBUTYNIN 5 MG TABLET, manufactured by Strides Pharma Inc., is $0.0473 per EA (NDC 64380016203), effective Jun 24, 2026.
How has the price of OXYBUTYNIN 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXYBUTYNIN 5 MG TABLET has declined 31.6%. It has been tracked across 204 weekly CMS publications since Aug 3, 2022.
What are the highest and lowest recorded NADAC prices for OXYBUTYNIN 5 MG TABLET?
Since Aug 3, 2022, the NADAC for OXYBUTYNIN 5 MG TABLET has ranged from a low of $0.0448 (Nov 20, 2024) to a high of $0.0765 (Nov 16, 2022), with a median of $0.0522 per EA.
Are there cheaper alternatives to OXYBUTYNIN 5 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as OXYBUTYNIN 5 MG TABLET, but none are currently priced below it.
Who manufactures OXYBUTYNIN 5 MG TABLET?
OXYBUTYNIN 5 MG TABLET (NDC 64380016203) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification